AHCL Anlon Healthcare Q2 FY26 results (Jul–Sep 2025) and concall
Anlon Healthcare reported strong Q2 and H1 FY26 financial performance, with significant revenue and PAT growth driven by operating leverage and improved business mix. The company is aggressively expanding capacity through a 700 metric ton greenfield facility and planned inorganic acquisitions, aiming for a total capacity of 1800-1900 metric tons and revenue of INR 520-540 crore by FY27/28. Anlon is focused on high-margin APIs, global market penetration, and expects to be debt-free by Q3 FY27, despite some pricing pressures in the API market.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 116.0%, net profit up 259.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 24 | 9 | 49 | 33 | 52 +116% |
| EBITDA | 8 | 1 | 17 | 6 | 14 +83% |
| Net profit | 3 | -2 | 17 | 4 | 9 +260% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
